Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo
Table 4
Distribution of biochemical and hematological parameters across disease severity groups.
Mild
Moderate
Severe
Critical
value
CRP (mg/L)
n (Mean rank)
8 (11.69)
23 (28.48)
50 (53.67)
4 (55.75)
≤0.001
D-dimer (ng/ml)
n (Mean rank)
8 (30.56)
20 (33.73)
48 (43.49)
4 (58.38)
0.097
LDH (U/L)
n (Mean rank)
0 (0.00)
16 (17.06)
33 (30.85)
4 (35.00)
0.008
CK (U/L)
n (Mean rank)
0 (0.00)
11 (17.91)
30 (23.32)
3 (31.17)
0.235
ESR (mm/h)
n (Mean rank)
4 (9.75)
21 (26.76)
38 (39.12)
4 (47.63)
0.003
WBC (×109/L)
n (Mean rank)
8 (14.25)
22 (40.00)
50 (47.74)
4 (47.25)
0.004
Granulocytes (%)
n (Mean rank)
8 (12.13)
19 (25.24)
43 (46.90)
4 (45.50)
≤0.001
Lymphocytes (%)
n (Mean rank)
8 (62.19)
20 (50.58)
44 (29.41)
4 (30.75)
≤0.001
Monocytes (%)
n (Mean rank)
8 (50.44)
18 (39.08)
33 (24.91)
4 (21.75)
0.001
Platelet count
n (Mean rank)
8 (33.75)
22 (43.07)
49 (45.40)
4 (11.00)
0.036
values less than 0.05 are highlighted in italics. Statistical analyses were performed with the Kruskal–Wallis test. IL-6, interleukin 6; CRP, C‐reactive protein; LDH, lactate dehydrogenase; CK, creatine kinase, ESR, erythrocyte sedimentation rate; WBC, white blood cells.
